Contribution of adrenergic receptors to anti-allodynic effect of mianserin in experimentally induced diabetic neuropathy model
Objective: Our research group previously reported that mianserin has the ability to reduce diabetic neuropathic pain at doses of 30 and 45 mg/kg, comparable to a widely prescribed drug, pregabalin (10 mg/kg), used in the clinical treatment of neuropathic pain. Based on this finding, in this study w...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Mesut Çetin
2021-02-01
|
| Серія: | Psychiatry and Clinical Psychopharmacology |
| Предмети: | |
| Онлайн доступ: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/1022 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|